- Home
- BARK vs TERN Comparison
BARK vs TERN Comparison
Compare BARK & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BARK
- TERN
- Stock Information
- Founded
- BARK 2011
- TERN 2017
- Country
- BARK United States
- TERN United States
- Employees
- BARK N/A
- TERN N/A
- Industry
- BARK Department/Specialty Retail Stores
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- BARK Consumer Discretionary
- TERN Health Care
- Exchange
- BARK Nasdaq
- TERN Nasdaq
- Market Cap
- BARK 342.7M
- TERN 382.2M
- IPO Year
- BARK N/A
- TERN 2021
- Fundamental
- Price
- BARK $1.91
- TERN $4.64
- Analyst Decision
- BARK Strong Buy
- TERN Buy
- Analyst Count
- BARK 3
- TERN 5
- Target Price
- BARK $2.30
- TERN $18.30
- AVG Volume (30 Days)
- BARK 1.1M
- TERN 1.7M
- Earning Date
- BARK 02-05-2025
- TERN 03-13-2025
- Dividend Yield
- BARK N/A
- TERN N/A
- EPS Growth
- BARK N/A
- TERN N/A
- EPS
- BARK N/A
- TERN N/A
- Revenue
- BARK $488,881,000.00
- TERN N/A
- Revenue This Year
- BARK $3.45
- TERN N/A
- Revenue Next Year
- BARK $7.35
- TERN N/A
- P/E Ratio
- BARK N/A
- TERN N/A
- Revenue Growth
- BARK N/A
- TERN N/A
- 52 Week Low
- BARK $0.87
- TERN $4.17
- 52 Week High
- BARK $2.56
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- BARK 46.59
- TERN 40.68
- Support Level
- BARK $1.86
- TERN $4.17
- Resistance Level
- BARK $1.99
- TERN $4.73
- Average True Range (ATR)
- BARK 0.11
- TERN 0.29
- MACD
- BARK -0.01
- TERN 0.02
- Stochastic Oscillator
- BARK 31.03
- TERN 47.98
About BARK BARK Inc.
BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.